Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does TRAZENTA Cause Interstitial lung disease? 5 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 5 reports of Interstitial lung disease have been filed in association with TRAZENTA. This represents 9.1% of all adverse event reports for TRAZENTA.

5
Reports of Interstitial lung disease with TRAZENTA
9.1%
of all TRAZENTA reports
0
Deaths
4
Hospitalizations

How Dangerous Is Interstitial lung disease From TRAZENTA?

Of the 5 reports, 4 (80.0%) required hospitalization, and 1 (20.0%) were considered life-threatening.

Is Interstitial lung disease Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for TRAZENTA. However, 5 reports have been filed with the FAERS database.

What Other Side Effects Does TRAZENTA Cause?

What Other Drugs Cause Interstitial lung disease?

METHOTREXATE (3,049) RITUXIMAB (2,458) PEMBROLIZUMAB (2,113) PREDNISONE (1,850) CYCLOPHOSPHAMIDE (1,725) NIVOLUMAB (1,538) AMIODARONE (1,421) DOXORUBICIN (1,352) ETANERCEPT (1,267) ADALIMUMAB (1,250)

Related Pages

TRAZENTA Full Profile All Interstitial lung disease Reports All Drugs Causing Interstitial lung disease TRAZENTA Demographics